The News Craving
Published by
The Bangkok Post
The Bangkok Post
Yong Poovorawan, chief of the Centre of Excellence in Clinical Virology at Chulalongkorn University, has said that Molnupiravir can help reduce the risk of hospitalisation or death among people suffering from Covid-19. Dr Yong said the medicine, developed by Merck, is highly effective if patients take it within five days of first experiencing symptoms. The doctor mentioned the results of research titled “Molnupiravir, an Oral Antiviral Treatment for Covid-19” published via medRxiv website which shows that the medicine was effective. “Molnupiravir is the first oral, direct-acting antiviral show…